Award
NIH Reporter #2R44DK136496-02
Hydrogel injection molded islet macroencapsulation devices to treat diabetes in a non-human primate model
Recipient
ImmunoShield Therapeutics Inc.
Award Amount
$913,868.00
Ceiling
$913,868.00
Awarded
September 03, 2025
Identifier
2R44DK136496-02
Award for developing hydrogel injection molded islet macroencapsulation devices to treat diabetes in non-human primates, generating data for FDA submissions.
Description
The project aims to evaluate hydrogel injection molded macroencapsulation devices for islet transplantation in non-human primate studies. The project will generate biocompatibility, toxicology, and CMC data for future FDA submissions. The project is funded by NIH and involves collaboration with ImmunoShield Therapeutics Inc.